Literature DB >> 30058451

Endovascular Retrieval of an Embolized Atrial Septal Occluder Device From the Abdominal Aorta.

Daniel A Crawford1, Sailen G Naidu2, Adil A Shah3, Victor J Davila4, William M Stone4.   

Abstract

Patent foramen ovale (PFO) is a common heart condition in adults. Closure with a septal occluder device is a safe, well-established treatment option with excellent clinical outcomes. One rare complication of percutaneous PFO closure is embolization of the device to the heart chambers or distal vasculature. Most device migrations are recognized during or shortly after implantation. While many endovascular retrievals of migrated devices are successful, there are still a high percentage of surgical interventions performed. We report a case of a septal occluder device that embolized to the abdominal aorta and was discovered 7 days after implantation. Endovascular techniques with a snare and endobronchial forceps were used to retrieve the device safely.

Entities:  

Keywords:  device removal; endovascular procedures; foreign body migration/diagnosis; foreign body migration/etiology; foreign body migration/surgery; septal occluder device/adverse effects

Mesh:

Year:  2018        PMID: 30058451     DOI: 10.1177/1538574418790393

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  2 in total

1.  A multi-center trial on efficacy and safety of the LifeTech CeraFlexTM ASD occluder for transcatheter closure in patients with secundum atrial septal defects.

Authors:  Celina Fritz; Andrea Engelhardt; Jochen Grohmann; Ingo Dähnert; Johanna Hummel; Daniel Tanase; Peter Ewert; Andreas Eicken
Journal:  Cardiovasc Diagn Ther       Date:  2022-08

2.  Conservative management of asymptomatic lately embolized amplatzer atrial septal occluder device to the supraceliac abdominal aorta: case report and the literature review.

Authors:  Samer Koussayer; Ahmed Mousa; Mai A Elkalla; Raghad Alaujan; Bassam Khalil
Journal:  Radiol Case Rep       Date:  2021-05-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.